In breast cancer, glutamine uptake induces tamoxifen resistance via the PI3K–AKT–PTEN pathway49, while glutaminolysis contributes to CDK4/6 inhibitor resistance in esophageal squamous cancer50. The gene discussed is CDK4; the disease is breast cancer.